Premium Nahrungsergänzungsmittel | artgerecht

Reticulocyte Analysis – Blood Test for Bone Marrow

Reticulocyte analysis is a blood test used to evaluate red blood cell production in the bone marrow. It measures immature red blood cells and aids in diagnosing anemia.

Regular tips about health Regular tips about health

Things worth knowing about "Reticulocyte Analysis"

Reticulocyte analysis is a blood test used to evaluate red blood cell production in the bone marrow. It measures immature red blood cells and aids in diagnosing anemia.

What Is Reticulocyte Analysis?

Reticulocyte analysis is a laboratory blood test that measures the number and characteristics of reticulocytes -- immature red blood cells that are released directly from the bone marrow into the bloodstream. Reticulocytes still contain remnants of ribonucleic acid (RNA), which disappears as they mature into fully developed erythrocytes. This test provides valuable information about the activity of red blood cell production, known as erythropoiesis, in the bone marrow.

How Is the Test Performed?

A small sample of venous blood is collected and analyzed in the laboratory. Modern laboratories use automated flow cytometry, in which cells are stained with fluorescent dyes that bind to RNA, allowing reticulocytes to be distinguished and counted automatically. Advanced analyzers can also determine additional parameters, including:

Reticulocyte Production Index (RPI): Indicates whether bone marrow activity is appropriate relative to the degree of anemia.
Immature Reticulocyte Fraction (IRF): Reflects the proportion of the youngest reticulocytes and provides insight into the speed of red blood cell production.
Reticulocyte Hemoglobin Content (Ret-He/CHr): Reflects the amount of iron currently available for red blood cell production.

When Is Reticulocyte Analysis Used?

This test is used in a variety of clinical situations, particularly for:

Evaluation and differential diagnosis of anemia
Distinguishing between reduced bone marrow production and increased red blood cell loss or destruction
Monitoring the response to anemia treatment, such as supplementation with iron, vitamin B12, or folic acid
Follow-up after bone marrow transplantation or stem cell transplantation
Assessing the effectiveness of erythropoietin (EPO) therapy
Early detection of functional iron deficiency before classic blood count parameters become abnormal

Reference Ranges and Interpretation

In healthy adults, reticulocytes typically account for 0.5 to 2.5 percent of all red blood cells, which corresponds to approximately 25,000 to 75,000 reticulocytes per microliter of blood. Results must always be interpreted in the context of the full blood count:

Elevated reticulocyte count (reticulocytosis): Indicates increased red blood cell production, as seen in hemorrhagic or hemolytic anemia, or as a response to successful nutrient deficiency treatment.
Decreased reticulocyte count (reticulocytopenia): Suggests reduced bone marrow activity, as seen in aplastic anemia, bone marrow disorders, severe iron deficiency, or vitamin B12 deficiency.

Clinical Significance

Reticulocyte analysis is an essential tool in modern hematology. It enables rapid and targeted differentiation of anemia subtypes and helps guide appropriate treatment decisions. The parameter reticulocyte hemoglobin content (Ret-He) is increasingly recognized as an early and sensitive marker of functional iron deficiency and is recommended in pediatric and nephrology guidelines. Compared to serum ferritin, Ret-He provides a more direct measure of the iron actually available for red blood cell production.

References

Brugnara C. - Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Critical Reviews in Clinical Laboratory Sciences, 37(2): 93-130 (2000). PubMed.
World Health Organization (WHO) - Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1 (2011). who.int.
Mast A.E. et al. - Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood, 99(4): 1489-1491 (2002). PubMed.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.